Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center (2020)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1111/tid.13243
- Subjects: HEPATITE B; MEDULA ÓSSEA; ESTUDOS RETROSPECTIVOS; ANTICORPOS MONOCLONAIS; REPLICAÇÃO VIRAL; HOSPEDEIRO IMUNOCOMPROMETIDO; IDOSOS; ANTIVIRAIS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Transplant infectious disease
- ISSN: 1398-2273
- Volume/Número/Paginação/Ano: v. 22, n. 2, article ID e13243, 9p, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BUZO, Bruno Fernando et al. Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center. Transplant infectious disease, v. 22, n. 2, 2020Tradução . . Disponível em: https://doi.org/10.1111/tid.13243. Acesso em: 24 jul. 2024. -
APA
Buzo, B. F., Ramos, J. F., Rossetti, R. A. M., Salles, N., Medrone-junior, A., Rocha, V. G., & Nastri, A. C. de S. S. (2020). Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center. Transplant infectious disease, 22( 2). doi:10.1111/tid.13243 -
NLM
Buzo BF, Ramos JF, Rossetti RAM, Salles N, Medrone-junior A, Rocha VG, Nastri AC de SS. Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center [Internet]. Transplant infectious disease. 2020 ; 22( 2):[citado 2024 jul. 24 ] Available from: https://doi.org/10.1111/tid.13243 -
Vancouver
Buzo BF, Ramos JF, Rossetti RAM, Salles N, Medrone-junior A, Rocha VG, Nastri AC de SS. Hepatitis B virus among hematopoietic stem cell transplant recipients: antiviral impact in seroconversion, engraftment, and mortality in a Latin American center [Internet]. Transplant infectious disease. 2020 ; 22( 2):[citado 2024 jul. 24 ] Available from: https://doi.org/10.1111/tid.13243 - Unrelated Cord Blood Transplantation for Acute Leukemia Diagnosed in the First Year of Life: Outcomes and Risk Factor Analysis
- Sickled cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation
- Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria
- Duffy null genotype or Fy(a-b-) phenotype are more accurate than self-declared race for diagnosing benign ethnic neutropenia in Brazilian population
- Prevalence of SMIM1 c.64_80del17 homozygotes in southeastern Brazil [Carta]: the Vel-negative phenotype
- Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
- Current role of interferon in hairy cell leukemia therapy: a timely decision
- Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.[Carta]
- Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation
- Low body mass index is associated with increased risk of acute GVHD after umbilical cord blood transplantation in children and young adults with acute leukemia: a study on behalf of Eurocord and the EBMT pediatric disease working party
Informações sobre o DOI: 10.1111/tid.13243 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
